Request a copy

Full Text

• Belaaouaj A., Kim K.S., and Shapiro S.D. Degradation of outer membrane protein A in Escherichia coli killing by neutrophil elastase. Science 289 (2000) 1185-1188
• Tkalcevic J., Novelli M., Phylactides M., Iredale J.P., Segal A.W., and Roes J. Impaired immunity and enhanced resistance to endotoxin in the absence of neutrophil elastase and cathepsin G. Immunity 12 (2000) 201-210
• Kawabata K., Hagio T., and Matsuoka S. The role of neutrophil elastase in acute lung injury. Eur J Pharmacol 451 (2002) 1-10
• Chua F., and Laurent G.J. Neutrophil elastase: mediator of extracellular matrix destruction and accumulation. Proc Am Thorac Soc 3 (2006) 424-427
• Coakley R.J., Taggart C., O'Neill S., and McElvaney N.G. Alpha1-antitrypsin deficiency: biological answers to clinical questions. Am J Med Sci 321 (2001) 33-41
• Tirouvanziam R. Neutrophilic inflammation as a major determinant in the progression of cystic fibrosis. Drug News Perspect 19 (2006) 609-614
• Lapperre T.S., Willems L.N., Timens W., Rabe K.F., Hiemstra P.S., Postma D.S., et al. Small airways dysfunction and neutrophilic inflammation in bronchial biopsies and BAL in COPD. Chest 131 (2007) 53-59
• Chua F., Dunsmore S.E., Clingen P.H., Mutsaers S.E., Shapiro S.D., Segal A.W., et al. Mice lacking neutrophil elastase are resistant to bleomycin-induced pulmonary fibrosis. Am J Pathol 170 (2007) 65-74
• Simpson J.L., Scott R.J., Boyle M.J., and Gibson P.G. Differential proteolytic enzyme activity in eosinophilic and neutrophilic asthma. Am J Respir Crit Care Med 172 (2005) 559-565
• Guay C., Laviolette M., and Tremblay G.M. Targeting serine proteases in asthma. Curr Top Med Chem 6 (2006) 393-402
• Reid P.T., and Sallenave J.M. Neutrophil-derived elastases and their inhibitors: potential role in the pathogenesis of lung disease. Curr Opin Investig Drugs 2 (2001) 59-67
• Tremblay G.M., Janelle M.F., and Bourbonnais Y. Anti-inflammatory activity of neutrophil elastase inhibitors. Curr Opin Investig Drugs 4 (2003) 556-565
• Fylaktakidou K.C., Hadjipavlou-Litina D.J., Litinas K.E., and Nicolaides D.N. Natural and synthetic coumarin derivatives with anti-inflammatory/ antioxidant activities. Curr Pharm Des 10 (2004) 3813-3833
• Doucet C., Pochet L., Thierry N., Pirotte B., Delarge J., and Reboud-Ravaux M. 6-Substituted 2-oxo-2H-1-benzopyran-3-carboxylic acid as a core structure for specific inhibitors of human leukocyte elastase. J Med Chem 42 (1999) 4161-4171
• Murray R.D.H., Mendez J., and Brown R.A. The Natural Coumarins (1982), J. Wiley & Sons, New York
• Siddiqui A.A., Rajesh R., Alagarsamy V., and De Clercq E. Synthesis, antiviral, antituberculostic, and antibacterial activities of some novel, 4-(4-substituted phenyl)-6-(4-nitrophenyl)-2-(substituted imino)pyrimidines. Arch Pharm (Weinheim) 340 (2007) 95-102
• Paya M., Halliwell B., and Hoult J.R. Interactions of a series of coumarins with reactive oxygen species. Scavenging of superoxide, hypochlorous acid and hydroxyl radicals. Biochem Pharmacol 44 (1992) 205-214
• Paya M., Goodwin P.A., De Las Heras B., and Hoult J.R. Superoxide scavenging activity in leukocytes and absence of cellular toxicity of a series of coumarins. Biochem Pharmacol 48 (1994) 445-451
• Hardt T.J., and Ritschel W.A. Investigation of the dose-response relationship upon intraperitoneal administration of coumarin and 7-hydroxycoumarin on the carrageenan induced edema of the rat hind paw. Arzneimittelforschung 33 (1983) 1662-1666
• Hoult J.R., Forder R.A., de las Heras B., Lobo I.B., and Paya M. Inhibitory activity of a series of coumarins on leukocyte eicosanoid generation. Agents Actions 42 (1994) 44-49
• Grimm E.L., Brideau C., Chauret N., Chan C.C., Delorme D., Ducharme Y., et al. Substituted coumarins as potent 5-lipoxygenase inhibitors. Bioorg Med Chem Lett 16 (2006) 2528-2531
• Raghav S.K., Gupta B., Shrivastava A., and Das H.R. Inhibition of lipopolysaccharide-inducible nitric oxide synthase and IL-1beta through suppression of NF-kappaB activation by 3-(1′-1′-dimethyl-allyl)-6-hydroxy-7-methoxy-coumarin isolated from Ruta graveolens L. Eur J Pharmacol 560 (2007) 69-80
• Kim H.J., Jang S.I., Kim Y.J., Chung H.T., Yun Y.G., Kang T.H., et al. Scopoletin suppresses pro-inflammatory cytokines and PGE2 from LPS-stimulated cell line, RAW 264.7 cells. Fitoterapia 75 (2004) 261-266
• Corsini E., Lucchi L., Binaglia M., Viviani B., Bevilacqua C., Monastra G., et al. Cloricromene, a semi-synthetic coumarin derivative, inhibits tumor necrosis factor-alpha production at a pre-transcriptional level. Eur J Pharmacol 418 (2001) 231-237
• Pochet L., Doucet C., Dive G., Wouters J., Masereel B., Reboud-Ravaux M., et al. Coumarinic derivatives as mechanism-based inhibitors of alpha-chymotrypsin and human leukocyte elastase. Bioorg Med Chem 8 (2000) 1489-1501
• Pochet L., Doucet C., Schynts M., Thierry N., Boggetto N., Pirotte B., et al. Esters and amides of 6-(chloromethyl)-2-oxo-2H-1-benzopyran-3-carboxylic acid as inhibitors of alpha-chymotrypsin: significance of the "aromatic" nature of the novel ester-type coumarin for strong inhibitory activity. J Med Chem 39 (1996) 2579-2585
• Reboud-Ravaux M, Pochet L, Doucet C, Pirotte B, Boggetto N, Delarge J. Nouveaux dérivés de coumarines, leurs procédés de préparation et leur application comme médicaments en tant qu'inhibiteurs de protéases (Preparation of coumarin derivatives as protease inhibitors) Brevet Français n° 97 06814, 3/6/97; PCT/FR98/01087, 29/5/98; WO 98/55472.
• Sirois J., Menard G., Moses A.S., and Bissonnette E.Y. Importance of histamine in the cytokine network in the lung through H2 and H3 receptors: stimulation of IL-10 production. J Immunol 164 (2000) 2964-2970
• Vachon E., Bourbonnais Y., Bingle C.D., Rowe S.J., Janelle M.F., and Tremblay G.M. Anti-inflammatory effect of pre-elafin in lipopolysaccharide-induced acute lung inflammation. Biol Chem 383 (2002) 1249-1256
• Tremblay G.M., Vachon E., Larouche C., and Bourbonnais Y. Inhibition of human neutrophil elastase-induced acute lung injury in hamsters by recombinant human pre-elafin (trappin-2). Chest 121 (2002) 582-588
• Janelle M.F., Doucet A., Bouchard D., Bourbonnais Y., and Tremblay G.M. Increased local levels of granulocyte colony-stimulating factor are associated with the beneficial effect of pre-elafin (SKALP/trappin-2/WAP3) in experimental emphysema. Biol Chem 387 (2006) 903-909
• Fujie K., Shinguh Y., Yamazaki A., Hatanaka H., Okamoto M., and Okuhara M. Inhibition of elastase-induced acute inflammation and pulmonary emphysema in hamsters by a novel neutrophil elastase inhibitor FR901277. Inflamm Res 48 (1999) 160-167
• Cataldo D.D., Gueders M.M., Rocks N., Sounni N.E., Evrard B., Bartsch P., et al. Pathogenic role of matrix metalloproteases and their inhibitors in asthma and chronic obstructive pulmonary disease and therapeutic relevance of matrix metalloproteases inhibitors. Cell Mol Biol (Noisy-le-Grand) 49 (2003) 875-884
• Tan R.J., Fattman C.L., Niehouse L.M., Tobolewski J.M., Hanford L.E., Li Q., et al. Matrix metalloproteinases promote inflammation and fibrosis in asbestos-induced lung injury in mice. Am J Respir Cell Mol Biol 35 (2006) 289-297
• Kraal G., Broug E., Thepen T., Van Iwaarden J.F., and Persoons J.H.A. The role of alveolar macrophages in pulmonary immune function. In: Lipscomb M.F., and Russell S.W. (Eds). Lung macrophages and dendritic cells in health and disease (1997), Marcel Dekker Inc., New York 203-220
• Chelen C.J., Fang Y., Freeman G.J., Secrist H., Marshall J.D., Hwang P.T., et al. Human alveolar macrophages present antigen ineffectively due to defective expression of B7 costimulatory cell surface molecules. J Clin Invest 95 (1995) 1415-1421
• Steinmuller C., Franke-Ullmann G., Lohmann-Matthes M.L., and Emmendorffer A. Local activation of nonspecific defense against a respiratory model infection by application of interferon-gamma: comparison between rat alveolar and interstitial lung macrophages. Am J Respir Cell Mol Biol 22 (2000) 481-490
• Black R.A. Tumor necrosis factor-alpha converting enzyme. Int J Biochem Cell Biol 34 (2002) 1-5
• Opalek J.M., Ali N.A., Lobb J.M., Hunter M.G., and Marsh C.B. Alveolar macrophages lack CCR2 expression and do not migrate to CCL2. J Inflamm (Lond) 4 (2007) 19-29
• Ishihara K., Yamaguchi Y., Okabe K., and Ogawa M. Neutrophil elastase enhances macrophage production of chemokines in receptor-mediated reaction. Res Commun Mol Pathol Pharmacol 103 (1999) 139-147
• Misumi T., Tanaka T., Mikawa K., Nishina K., Morikawa O., and Obara H. Effects of sivelestat, a new elastase inhibitor, on IL-8 and MCP-1 production from stimulated human alveolar epithelial type II cells. J Anesth 20 (2006) 159-165
• Doucet A., Bouchard D., Janelle M.F., Bellemare A., Gagne S., Tremblay G.M., et al. Characterization of human pre-elafin mutants: full antipeptidase activity is essential to preserve lung tissue integrity in experimental emphysema. Biochem J 405 (2007) 455-463
• Eutamene H., Theodorou V., Schmidlin F., Tondereau V., Garcia-Villar R., Salvador-Cartier C., et al. LPS-induced lung inflammation is linked to increased epithelial permeability: role of MLCK. Eur Respir J 25 (2005) 789-796
• Hagio T., Matsumoto S., Nakao S., Matsuoka S., and Kawabata K. Sivelestat, a specific neutrophil elastase inhibitor, prevented phorbol myristate acetate-induced acute lung injury in conscious rabbits. Pulm Pharmacol Ther 18 (2005) 285-290
• Koga H., Kanehiro A., Miyahara N., Ikeda G., Fuchimoto Y., Waseda K., et al. Neutrophil elastase inhibitor attenuates allergen-induced airway inflammation and airway hyperresponsiveness in a model of secondary allergen challenge. Am J Respir Crit Care Med 177 (2008) A978